Moreover, the rescue of Th17-mediated neuronal death could be achieved by blocking ICAM-1 and IL-17R, or by blocking LFA-1 and IL-17 in Th17 cells with anti-IL-17 antibodies, directs us toward new potential immunotherapeutic targets for PD [67, 119]. The gene discussed is ICAM1; the disease is Parkinson disease.